Amgen Launches Humira Biosimilar, Amgevita, in Markets Across Europe
News
Amgen recently launched Amgevita, a biosimilar to Abbvie’s Humira (adalimumab), in Europe after approval by the European Commission. The therapy will be available in the 28 countries of the European Union, plus ... Read more